Pharm 422 Flashcards

Exam 3

1
Q

These anti-diabetic drugs block the reabsorption of glucose in the proximal tubule of the kidney and allow glucose to be excreted in the urine.

A

SLGT-2 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
These anti-diabetic drugs:
Canagliflozin (Invokana)
Dapagliflozin (Farxiga)
Empagliflozin (Jardiance)
are part of what class?
A

SLGT-2 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
side effect of these anti-diabetic drugs include:
Hypotension
dehydration
hyperkalemia
weight loss
UTI
Genital fungal infection
Increase in urination
small increase in LDL 
decrease in renal function
A

SLGT-2 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sulfonlyureas & antihypertensive drugs can have an interaction with these anti-diabetic drugs

A

SLGT-2 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

SLGT-2 inhibitors contraindicated in what conditions or populations?

A

Severe renal impairment
Type I Diabetes
Children & breastfeeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Gliflozins are part of what anti-diabetic med family?

A

SLGT-2 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

GLP-1 Agonist

non-insulin injectable

A

Incretins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MOA of Incretins (GLP-1 agonist)

A
  • Promotes insulin release from beta pancreatic cells
  • Suppresses release of glucagon from alpha cells
  • Slows gastric emptying
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Promotes insulin release from beta pancreatic cells
Suppresses release of glucagon from alpha cells
slows gastric emptying

A

MOA of Incretins (GLP-1 agonist)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
What class of anti-diabetc drugs do these belong in?
Exenatide (Byetta, Bydureon)
Liraglutide (Victoza)
Lixisenatide (Adlyxin)
Dulaglutide (Trulicity)
A

GLP-1 agonist drugs (Incretins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Less hypoglycemia with these medications, insulin is only released in response to food. So, unlike the sulfonlyurias that Stimulate insulin release regardless of food intake

A

GLP-1 agonist drugs (Incretins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Contraindications for GLP-1 agonist drugs (Incretins)

A

Type I diabetes
gastroparesis
Acute pancreatitias
Preg Cat C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

If thyroid CA is present, avoid this class of med anti-diabetic drugs

A

GLP-1 agonist drugs (Incretins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
weight loss 8-10lbs common with this class of med anti-diabetic drugs
Preg Cat C
A

GLP-1 agonist drugs (Incretins)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Side effects of GLP-1 agonist drugs (Incretins)

A

N/V, diarrhea, dyspepsia & hypoglycemia when paired with sulfonlyurea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

DPP-4 Inhibitors MOA

A

slows inactivation of the incretins (GLP-1 & GIP) keeping glucose levels low by inhibiting DPP-4 enzyme

17
Q

“Gliptins”

A

DPP-4 Inhibitors

18
Q

Enhance activity of GLP-1, they inhibit DPP-4 and it leads to increase in the secretion of insulin & supresses the
release of glucagon by the pancreas.

A

DPP-4 Inhibitors

19
Q

side effects of DPP-4 inhibitors

A

URI, UTI, Headache, angioedema

20
Q

Can increase hypoglycemic effects of DPP-4 inhibitors

A

sulfonylureas, insulin & ACE-I

21
Q

you get increased levels of gliptons (DPP-4 inhibitors) with these drugs

A

SSRIs
salicylates
Quinolone antibiotics

22
Q

you get decreased levels of gliptons (DPP-4 inhibitors) with these drugs

A

CYP 3A4 inducers
Quinolone antibiotics
Thiazide diuretics

23
Q

Dosing for DPP-4 inhibotrs

A
  • One oral in the morning

- Monotherapy or in combination with other antidiabetic drugs

24
Q

ADA & AACE recommend HbA1c less than for
to be considered diabetic
and to reach treatment goals
FBG

A

> 6.5 - 7 %
< 6.5%

> 126 mg/dL